Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Merck
Merck
Pro-Life Groups say Merck is Partly to Blame for Measles Outbreaks
WSJ Pharmalot
Fri, 01/30/15 - 02:32 pm
vaccines
measles
Merck
MMR
Drugmakers receive mysterious invites to White House
CNBC
Wed, 01/28/15 - 08:00 pm
R&D
personalized medicine
Obama
Merck
Regeneron
Vertex Pharmaceuticals
Cheaper Vaccines By Serum Institute Of India To Seize Merck & Co.’s (MRK) Market Share
Bidness Etc.
Wed, 01/28/15 - 11:30 am
India
Serum Institute
generics
vaccines
HPV
Merck
GSK
Cervarix
Gardasil
Ebola Vaccines May Get Faster Approval Amid Outbreak’s Wane
Bloomberg
Thu, 01/22/15 - 03:48 pm
vaccines
approvals
ebola virus
GSK
Merck
NewLink Genetics
Merck Will No Longer Sell its Victrelis Hepatitis C Drug in the U.S.
WSJ Pharmalot
Wed, 01/21/15 - 11:40 am
Merck
Victrelis
hepatitis C
Merck Completes Tender Offer to Acquire Cubist
Yahoo
Wed, 01/21/15 - 09:18 am
Merck
M&A
Cubist Pharmaceuticals
FirstWord Lists – The drugs that will shape 2015
First Word Pharma
Mon, 01/19/15 - 04:14 pm
Harvoni
Viekira Pak
Gilead Sciences
AbbVie
alirocumab
evolocumab
Amgen
Regeneron
Sanofi
Opdivo
Keytruda
Merck
Bristol-Myers Squibb
Novartis
CTL019
Zarxio
Pfizer
palbociclib
Saxenda
Trulicity
Afrezza
MannKind
Eli Lilly
Novo Nordisk
LCZ696
Toujeo
Breo Ellipta
GED-0301
Celgene
BiogenIdec
Exclusive: Merck funds tests of lower Zilmax doses as seen seeking way to resume sales
Reuters
Mon, 01/19/15 - 12:03 pm
Merck
Zilmax
animal health
Merck Is DJIA Top Stock In 2015
24/7 Wall St.
Sun, 01/18/15 - 10:45 am
Merck
Merck CEO Frazier credits Keytruda success to slim-down strategy
Fierce Pharma
Tue, 01/13/15 - 10:47 am
Merck
Pharma CEOs
Kenneth Frazier
Keytruda
Yervoy
melanoma
Lilly to Pair With Merck, Bristol on Cancer Drug Trials
WSJ Online
Tue, 01/13/15 - 09:54 am
Eli Lilly
Merck
Bristol-Myers Squibb
immunotherapy
clinical trials
Merck Joins Messenger RNA Frenzy, Betting $100M on Moderna Therapeutics
Forbes
Tue, 01/13/15 - 08:52 am
Merck
Moderna Therapeutics
messenger RNA
MRNA
Merck and Bristol-Myers Rivalry in Cancer Drugs Heats Up, Again
WSJ Pharmalot
Mon, 01/12/15 - 12:52 pm
Merck
Bristol-Myers Squibb
Keytruda
Opdivo
Merck speeds up drug-submission plans for Hep C, lung cancer -WSJ
Yahoo/Reuters
Mon, 01/12/15 - 08:22 am
Merck
hepatitis C
non-small cell lung cancer
Keytruda
grazoprevir
elbasvir
Is Gilead Sciences Inc. Now a Takeover Target?
Motley Fool
Fri, 01/9/15 - 08:29 am
Gilead Sciences
M&A
Novartis
Pfizer
JNJ
Merck
Glaxo, Merck Ebola Vaccine Trials to Start in Liberia
Bloomberg
Fri, 01/9/15 - 08:27 am
GSK
Merck
vaccines
Liberia
ebola virus
Cubist: Zerbaxa Upholds The Potential To Replace Cubicin
Seeking Alpha
Mon, 01/5/15 - 04:06 pm
Cubist Pharma
antibiotics
Zerbaxa
Cubicin
Merck
Can study data spur Merck CV sales?
Medical Marketing and Media
Mon, 01/5/15 - 09:36 am
Merck
Zetia
Vytorin
Merck-NewLink Ebola vaccine trial resumes at lower dose -Geneva hospital
Yahoo/Reuters
Mon, 01/5/15 - 09:08 am
Merck
NewLink Genetics
vaccines
ebola virus
clinical trials
Grading Pharma In 2014: 17 Drug Companies Ranked
Forbes
Sun, 01/4/15 - 10:24 pm
Actavis
Celgene
Amgen
AbbVie
Gilead Sciences
Eli Lilly
Novartis
AstraZeneca
Merck
JNJ
Biogen Idec
Novo Nordisk
Roche
Bristol-Myers Squibb
Pfizer
GSK
Sanofi
Pages
« first
‹ previous
…
97
98
99
100
101
102
103
104
105
…
next ›
last »